Search Results - Blijenberg, B.G.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    The value of (−7, −5)pro‐prostate‐specific antigen and human kallikrein‐2 as serum markers for grading prostate cancer

    The value of (−7, −5)pro‐prostate‐specific antigen and human kallikrein‐2 as serum markers for grading prostate cancer by Bangma, C.H., Wildhagen, M.F., Yurdakul, G., Schröder, F.H., Blijenberg, B.G.

    Published in BJU international
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Discordant performance of assays for free and total prostate‐specific antigen in relation to the early detection of prostate cancer

    Discordant performance of assays for free and total prostate‐specific antigen in relation to the early detection of prostate cancer by Blijenberg, B.G., Yurdakul, G., Van Zelst, B.D., Bangma, C.H., Wildhagen, M.F., Schröder, F.H.

    Published in BJU international
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Different PSA Assays Lead to Detection of Prostate Cancers with Identical Histological Features

    Different PSA Assays Lead to Detection of Prostate Cancers with Identical Histological Features by Yurdakul, G, Bangma, C.H, Blijenberg, B.G, van Zelst, B.D, Wildhagen, M.F, van der Kwast, Th.H, Schröder, F.H

    Published in European urology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Quality assessment for prostate‐specific antigen (PSA) in relation to ERSPC: report of the PSA Committee

    Quality assessment for prostate‐specific antigen (PSA) in relation to ERSPC: report of the PSA Committee by Blijenberg, B.G., Lilja, H., Neels, H., Stenman, U.‐H.

    Published in BJU international
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Disease monitoring by the tumour markers Cyfra 21.1 and TPA in patients with non-small cell lung cancer

    Disease monitoring by the tumour markers Cyfra 21.1 and TPA in patients with non-small cell lung cancer by van der Gaast, A., Kok, T.C., Kho, G.S., Blijenberg, B.G., Splinter, T.A.W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Free and total prostate‐specific antigen in a screened population

    Free and total prostate‐specific antigen in a screened population by BANGMA, C.H., KRANSE, R., BLIJENBERG, B.G., SCHRÖDER, F.H.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: